Therefore, this cPLA2-mediated abnormal signaling cascade is a hallmark of impaired insulin sensitivity, linking metabolic and neurodegenerative disorders and reinforcing the connection between AD and diabetes. This evidence concerns the gene PLA2G4A and Alzheimer disease.